Biopharmacy
Our research team investigates the fundamental biological and pharmacological principles underpinning drug functions. We aims to translate our research findings for clinical and therapeutic benefit.
CURRENT ACTIVE PROJECTS:
Dr Norsyafinaz Yaakob
Investigating the effects of 5-HT3 antagonists and gingerol-rich Zingiber officinale extract on chronic nicotine addiction & toxicity in rodents.
Dr Chua Eng Wee
Understanding the genetic basis of the Neuroprotective effect of caffeine on the developing brain using an in vitro CRISPR gene-editing system.
The genetic basis of caffeine sensitivity is not well understood. We are using CRISPR to create a cell model that would allow us to gauge the effect of a DNA variant in the ADORA1 gene – the therapeutic target of caffeine – on caffeine response.
Optimising the amplification of long DNA fragments: the role of PCR additives and emulsion PCR.
Dr Mohd Kaisan Mahadi
Transcutaneous vagus nerve stimulation: Investigation on macrophage polarisation through cholinergic anti-inflammatory pathway in rats with induced myocardial infarction.
The proposed pathway of autonomic neuromodulation from transcutaneous vagus nerve stimulation. Image acquired from Murray et al 2016.
EXTERNAL COLLABORATORS:
PROUDLY SPONSORED BY: